COVID-19 Booster Dose 

A Multi-center, Randomized, Blinded, Placebo-controlled, Phase 3 Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of SARS-CoV-2 Bivalent mRNA Vaccine (LVRNA021) as Booster in Participants Aged 18 Years and Older who Completed Primary/1 Booster Dose(s) of SARS-CoV-2 Vaccination Study Status: Recruitment Completed  Thanks to All the Participants and their families for the active participation […]

COVID-19 Treatment

A Phase 3, multicenter, randomized, double-blind, 48-week study of the clinical and antiviral effect of S 217622 compared with placebo in non-hospitalized high risk participants with COVID 19 Study Status: Recruitment started 

Trials in Pipeline

Trial Name Disease Area CML Oncology Breast cancer Oncology CABG Cardiology Fungal infection evaluation Infectious Diseases Alzheimer’s Disease Neurology Alkylosing Spondyloarthritis Rheumatology Advanced Melanoma Oncology Multiple Myeloma Oncology Breast Cancer Oncology Niemen’s Pick Disease Rare Genetic Disease Bacterial Infections Infectious Diseases Stroke treatment Neurology Flu Infectious diseases NSCLC Oncology Bacterial Infections Infectious Disease Stroke Treatment […]